HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Battery-Less Neurostimulator Treats Overactive Bladder

By HospiMedica International staff writers
Posted on 27 Jun 2016
Print article
Image: The new neurostimulation device is designed to treat an overactive bladder (Photo courtesy of UGNM).
Image: The new neurostimulation device is designed to treat an overactive bladder (Photo courtesy of UGNM).
A miniature wireless neurostimulation device could help improve the quality of life for patients with overactive bladder (OAB).

The Bluewind Medical OAB-1000 is a wireless, battery-less neurostimulator, which is 90% smaller than current typical neurostimulators, allowing physicians to treat OAB with a minimally invasive simple surgical procedure that places it near the tibial nerve, in the lower leg. The device electrically stimulates the tibial nerve, which influences urinary function, and is powered wirelessly by an external control unit worn by the patient for only 30 minutes which can also be used while performing daily tasks without interruption.

“Today, neurostimulators that treat OAB are large, bulky, and require complex and expensive surgery. BlueWind's implantable microstimulators are significantly smaller, allow for a simple implant procedure, and are easier for patients to use at home,” said Guri Oron, CEO of Bluewind, a company of Rainbow Medical (Herzeliya Pituach, Israel). “This is the first product out of many in our pipeline that will transform neurostimulation and by that, will enable the treatment of millions of additional patients.”

“The device was easy to implant, activate and use. European participants in the study liked the idea of such a small implant and a very short procedure,” said Sohier Elneil, MD, of University College London (UCL; UK) and the National Hospital for Neurology and Neurosurgery (NHNN; London, UK). “They were very favorable to having the flexibility and sense of control by treating themselves at home. The patients were also relieved from the burden of logistics associated with therapy in the clinic.”

Percutaneous neuromodulation (PTNM) works by delivering a gentle electrical pulse to the tibial nerve in the skin near the ankle via a neurostimulator. The electrical stimulation is thought to indirectly activate the central nervous system (CNS) to help alleviate OAB symptoms such as urinary frequency, urinary incontinence, and urge incontinence episodes.

Related Links:
Rainbow Medical
National Hospital for Neurology and Neurosurgery
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Illuminated Retractor System
HandLite

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more